Property	Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes

Steven A. Edmundowicz MD, MASGE Associate Editor

Scott J. Cotler MD Associate Editor

See All Experts

featured

Published in Gastroenterology and

Journal Scan / Research · October 20, 2022

COVID-19 Vaccination Response in Patients With IBD on Immune-Modifying Therapy

Inflammatory Bowel Diseases

Save Recommend

Sign in to PracticeUpdate

Only registered members have full access to PracticeUpdate content.

Not a member?

Join for free

Disclosure statements are available on the authors' profiles:

Amar Naik MD

Inflammatory Bowel Diseases

Anti-SARS-CoV-2 Vaccination and Antibody Response in Patients With Inflammatory Bowel Disease on Immune-modifying Therapy: Prospective Single-Tertiary Study

Inflamm. Bowel Dis. 2022 Oct 03;28(10)1506-1512, K Cerna, D Duricova, M Lukas, N Machkova, V Hruba, K Mitrova, K Kubickova, M Kostrejova, V Teplan, M Vasatko, K Kastylova, M Lukas

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

COVID-19

COVID-19 Vaccination Response in Patients With IBD on Immune-Modifying Therapy

Additional Info

Anti-SARS-CoV-2 Vaccination and Antibody Response in Patients With Inflammatory Bowel Disease on Immune-modifying Therapy: Prospective Single-Tertiary Study

Further Reading

MRI and High-Resolution Manometry to Predict Response to Bisacodyl and Hyoscine for Constipation

Association Between Vibration-Controlled Transient Elastography–Based Parameters and Clinical Outcomes in Liver Transplant Recipients

Distinct and Shared Features of Gastroparesis and Functional Dyspepsia

Intensified- vs Standard-Dose Infliximab Induction Therapy for Steroid-Refractory Acute Severe Ulcerative Colitis

Outcomes of an Intervention Combining Energy Restriction and Exercise in Patients With MASH

Clinical Management: Colorectal Intramucosal Carcinoma vs High-Grade Dysplasia and T1 Colorectal Cancer

Liver Transplantation in Patients With Wilson Disease: Current Knowledge and Future Perspectives

Association of Risankizumab Concentration and IL-22 Levels With Clinical and Biochemical Remission of Crohn's Disease

Type, Duration, and Severity of Pre-Transplantation Kidney Injury Predict Prolonged Kidney Dysfunction After Liver Transplantation

Association Between Inflammatory Markers at Birth and the Risk of Early-Onset IBD

Intensive Locoregional Therapy Before Liver Transplantation for Colorectal Cancer Liver Metastasis: A Novel Pre-Transplantation Protocol

Recently Updated